Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 20

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 20
---
 except as otherwise provided by specific
statute, no director or officer of a corporation is individually liable for a debt or liability of the corporation, unless the director
or officer acts as the alter ego of the corporation. The court as a matter of law must determine the question of whether a director or
officer acts as the alter ego of a corporation.

Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended, may be permitted to directors, offices or controlling persons of ours, pursuant to the foregoing provisions,
or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the
Securities Act of 1933, as amended, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by us of expenses incurred or paid by a director, officer or controlling person of ours in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered hereunder, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities
Act of 1933, as amended, and will be governed by the final adjudication of such issue.

<div align='center'>II-2</div>

Item 7. Exemption from Registration Claimed.

Not applicable.

Item 8. Exhibits.

| Exhibit Number 
 4.1            
 4.2            |     | Description                                                                                                                                                                 
 Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 filed with the SEC on August 30, 2018).                       
 Bylaws (Incorporated by reference to Exhibit 3.2 to the Registration Statement on Form S-1 filed with the SEC on August 30, 2018).                                          |
|:---------------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3            |     | First Amendment to the Bylaws of INmune Bio Inc. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 23, 2024). |
| 5.1            |     | Opinion of S